Target is a premium stock of StocksGuide. Please log in to activate an alert for Target.
Register for Free
Please register for free to add Target to your portfolio.
Target Stock News
$87.62
4.71%
yesterday
NYSE,
Nov 21, 10:14 pm CET
Why the stock moved Beta
StocksGuide Unlimited – full access to AI analyses
With Unlimited you get the full AI functionality for Target. 👉 More detailed insights 👉 Exclusive perspectives on opportunities & risks 👉 Clear answers to your questions
Nvidia (NVDA) delivered strong earnings driven by 66% data center growth, but shares fell as markets turned cautious. Retail sector saw divergent results: Walmart (WMT) outperformed with strong e-commerce and value focus, while Target (TGT) and Home Depot (HD) struggled.
It's a proverbial tale of two retailers: the best of times for Walmart, the worst of times for Target. Both companies are preparing for leadership changes at the top, yet Walmart's incoming CEO has wind at his back, while Target's successor faces daunting challenges.
Target NYSE: TGT is trading in deep-value territory, offering a projected 5% dividend yield in late 2025, but that alone may not be enough reason to buy in. Despite some potential for recovery in 2026, near-term headwinds remain strong.
Barclays strategists raised their year-end 2026 expectation for the S&P 500 , implying an 11.4% gain from the benchmark's Wednesday close, citing strength in megacap technology along with an improving monetary and fiscal backdrop despite low growth.
Germany will not hit its own 3.5% defence spending target in 2029, Defence Minister Boris Pistorius said on Wednesday, as the country ramps up spending in the wake of Russia's war with Ukraine.
Get Forbes Breaking News Text Alerts: We're launching text message alerts so you'll always know the biggest stories shaping the day's headlines. Text “Alerts” to (201) 335-0739 or sign up here: joinsubtext.com/forbes.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.